ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products.[1]
Market PositionThe company is a leading player in the domestic branded formulations market. It is the youngest among the top 20 companies in the Indian Pharmaceutical Market.[1]
| S.No. | Name | Current Price (Rs.) | Price to Earning | Market Capitalization (Rs.Cr.) | Dividend yield (%) | Net Profit latest quarter (Rs.Cr.) | YOY Quarterly profit growth (%) | Sales latest quarter (Rs.Cr.) | YOY Quarterly sales growth (%) | Return on capital employed (%) | Sales (Rs.Cr.) | OPM (%) | Profit after tax (Rs.Cr.) | Profit after tax latest quarter (Rs.Cr.) | Price to book value | Return on assets (%) | Debt to equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | Sun Pharma.Inds. | 1760.20 | 36.58 | 422330.94 | 0.91 | 3124.95 | 2.56 | 14478.31 | 8.93 | 20.21 | 54964.01 | 30.12 | 11543.96 | 3117.95 | 5.43 | 12.97 | 0.07 |
| 2. | Divi's Lab. | 6642.50 | 70.96 | 176337.50 | 0.45 | 689.00 | 35.10 | 2715.00 | 16.12 | 20.44 | 10029.00 | 32.37 | 2485.00 | 689.00 | 11.44 | 13.53 | 0.01 |
| 3. | Torrent Pharma. | 3936.80 | 61.50 | 133239.20 | 0.81 | 591.00 | 32.49 | 3302.00 | 14.30 | 27.05 | 12248.00 | 32.60 | 2166.53 | 600.17 | 15.77 | 13.26 | 0.33 |
| 4. | Cipla | 1530.80 | 22.73 | 123653.62 | 0.85 | 1353.37 | 3.73 | 7589.44 | 7.64 | 22.72 | 28349.57 | 25.40 | 5441.14 | 1351.17 | 3.76 | 14.72 | 0.01 |
| 5. | Dr Reddy's Labs | 1256.20 | 18.16 | 104846.27 | 0.64 | 1336.80 | 7.28 | 8828.30 | 9.83 | 22.69 | 34310.00 | 24.64 | 5772.20 | 1347.10 | 2.91 | 12.95 | 0.16 |
| 6. | Lupin | 2149.70 | 22.71 | 98198.04 | 0.56 | 1484.83 | 73.34 | 7047.51 | 24.23 | 21.30 | 24750.69 | 27.25 | 4324.63 | 1477.92 | 5.00 | 12.41 | 0.32 |
| 7. | Zydus Lifesci. | 931.05 | 18.63 | 93685.42 | 1.18 | 1238.60 | 40.92 | 6123.20 | 16.92 | 24.31 | 24493.90 | 31.10 | 5029.35 | 1283.60 | 3.70 | 14.64 | 0.38 |
| 8. | ERIS Lifescience | 1552.00 | 75.02 | 21140.86 | 0.47 | 149.57 | 432.28 | 650.50 | 49.01 | 6.86 | 2033.64 | 36.08 | 281.81 | 149.57 | 7.63 | 1.44 | 0.79 |
| – | Median: 151 Co. | 405.75 | 30.68 | 1679.94 | 0.11 | 12.57 | 11.71 | 152.64 | 11.11 | 14.89 | 574.01 | 15.93 | 43.84 | 13.49 | 3.11 | 8.56 | 0.22 |
Standalone figures in ₹ crores
| Dec 2022 | Dec 2023 | Dec 2024 | Jun 2023 | Jun 2024 | Jun 2025 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 332 | 324 | 400 | 411 | 457 | 579 | 315 | 341 | 405 | 355 | 410 | 437 | 650 |
Expenses | 206 | 250 | 300 | 256 | 333 | 362 | 203 | 262 | 284 | 214 | 265 | 294 | 354 |
Operating Profit | 126 | 74 | 100 | 156 | 123 | 216 | 111 | 79 | 121 | 141 | 144 | 143 | 297 |
Other Income | 3 | 3 | 8 | 4 | 5 | 23 | 4 | 20 | 17 | 6 | 7 | 6 | 24 |
Profit before tax | 110 | 35 | 6 | 133 | 27 | 156 | 96 | 42 | 41 | 124 | 120 | 46 | 235 |
Tax % | 10% | 9% | 70% | 16% | 36% | 36% | 8% | 5% | 26% | 7% | 2% | 39% | 36% |
Net Profit | 99 | 32 | 2 | 111 | 17 | 100 | 88 | 40 | 30 | 115 | 118 | 28 | 150 |
EPS in Rs | 7.31 | 2.33 | 0.13 | 8.14 | 1.25 | 7.34 | 6.46 | 2.90 | 2.24 | 8.47 | 8.66 | 2.06 | 10.98 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 520 | 548 | 605 | 713 | 761 | 897 | 1,020 | 1,109 | 1,216 | 1,331 | 1,487 | 1,698 | 2,034 |
Expenses | 436 | 437 | 435 | 442 | 445 | 562 | 661 | 691 | 727 | 825 | 1,031 | 1,210 | 1,300 |
Operating Profit | 84 | 111 | 171 | 271 | 316 | 334 | 359 | 417 | 488 | 506 | 456 | 487 | 734 |
Other Income | 9 | 7 | 3 | 25 | 28 | 32 | 11 | 10 | 25 | 16 | 33 | 35 | 71 |
Interest | 0 | 0 | 0 | 1 | 10 | 23 | 2 | 1 | 3 | 21 | 57 | 220 | 199 |
Depreciation | 4 | 15 | 20 | 21 | 22 | 32 | 45 | 38 | 51 | 65 | 102 | 182 | 167 |
Profit before tax | 89 | 103 | 154 | 274 | 312 | 312 | 324 | 389 | 459 | 437 | 329 | 120 | 438 |
Net Profit | 65 | 83 | 138 | 248 | 294 | 285 | 291 | 351 | 417 | 398 | 300 | 77 | 282 |
EPS in Rs | 4,738.18 | 6,060.36 | 10,034.18 | 18.05 | 21.36 | 20.75 | 21.45 | 25.82 | 30.69 | 29.27 | 22.03 | 5.68 | 20.69 |
Dividend Payout % | 0% | 0% | 61% | 0% | 0% | 0% | 13% | 21% | 20% | 25% | 0% | 129% | – |
Standalone figures in ₹ crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.14 | 0.14 | 0.14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
Reserves | 184 | 267 | 305 | 561 | 854 | 1,142 | 1,286 | 1,562 | 1,905 | 2,208 | 2,510 | 2,501 | 2,757 |
Borrowings | 0 | 1 | 0 | 0 | 376 | 176 | 0 | 0 | 0 | 317 | 2,572 | 2,245 | 2,189 |
Other Liabilities | 83 | 86 | 96 | 82 | 126 | 138 | 183 | 179 | 232 | 245 | 254 | 463 | 477 |
Total Liabilities | 268 | 354 | 402 | 657 | 1,370 | 1,470 | 1,483 | 1,755 | 2,150 | 2,784 | 5,350 | 5,222 | 5,437 |
Fixed Assets | 64 | 61 | 65 | 92 | 490 | 484 | 601 | 584 | 642 | 898 | 1,516 | 2,412 | 2,352 |
Gross Block | 73 | 86 | 108 | 113 | 533 | 552 | 696 | 717 | 778 | 1,095 | 1,811 | 2,875 | – |
Accumulated Depreciation | 10 | 24 | 43 | 21 | 43 | 68 | 95 | 133 | 136 | 197 | 296 | 463 | – |
CWIP | 0 | 0 | 0 | 0 | 0 | 3 | 4 | 2 | 3 | 0 | 1 | 0 | 0 |
Investments | 98 | 182 | 206 | 381 | 546 | 580 | 320 | 531 | 778 | 997 | 1,619 | 991 | 991 |
Other Assets | 106 | 110 | 131 | 184 | 335 | 403 | 558 | 638 | 728 | 889 | 2,214 | 1,819 | 2,094 |
Total Assets | 268 | 354 | 402 | 657 | 1,370 | 1,470 | 1,483 | 1,755 | 2,150 | 2,784 | 5,350 | 5,222 | 5,437 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operating Activity | 90 | 92 | 133 | 210 | 236 | 216 | 265 | 395 | 369 | 322 | 336 | 702 |
Cash from Investing Activity | -85 | -94 | -45 | -199 | -593 | 2 | 127 | -348 | -268 | -513 | -2,492 | -359 |
Cash from Financing Activity | -0 | 1 | -84 | -18 | 363 | -221 | -334 | -81 | -88 | 194 | 2,160 | -310 |
Net Cash Flow | 5 | -1 | 4 | -6 | 7 | -2 | 58 | -34 | 13 | 3 | 4 | 32 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 16 | 16 | 15 | 21 | 29 | 31 | 50 | 37 | 41 | 63 | 59 | 51 |
Inventory Days | 130 | 181 | 156 | 161 | 194 | 206 | 145 | 119 | 155 | 98 | 119 | 140 |
Days Payable | 93 | 121 | 88 | 86 | 266 | 207 | 200 | 159 | 177 | 128 | 143 | 158 |
Cash Conversion Cycle | 52 | 75 | 84 | 97 | -43 | 30 | -4 | -3 | 19 | 33 | 35 | 33 |
Working Capital Days | 11 | 13 | 8 | 31 | 2 | -22 | 58 | 65 | 80 | 52 | -413 | -99 |
ROCE % | 56% | 44% | 53% | 62% | 35% | 26% | 24% | 27% | 27% | 20% | 10% | 7% |
Direct from BSE filings, auto-summarised
External media mentions & references
Editorial & research coverage
Nov 2025
Aug 2025
May 2025
Feb 2025
Nov 2024
Aug 2024
Jun 2024
Mar 2024
Feb 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Jan 2023
Oct 2022
Aug 2022
May 2022
Feb 2022
Jan 2022
Oct 2021
Aug 2021
Jul 2021
May 2021
Mar 2021
Jan 2021
Nov 2020
Aug 2020
Jun 2020
Jun 2020
Feb 2020
Nov 2019
Jul 2019
May 2019
Jan 2019
Nov 2018
Aug 2018
May 2018
Feb 2018
Nov 2017
Aug 2017
Stock Analysis
HCLTech is a global IT services company offering software-led IT solutions, remote infrastructure management, engineering and R&D services, and BPO. It leverages its extensive global offshore infrastructure and network of offices to deliver multi-service solutions across key industry verticals.
HCLTech's growth is fueled by its strong AI strategy, robust deal wins ($3 billion bookings in Q3 FY26), and strategic acquisitions like HPE's Telco business and CSG's Jaspersoft, enhancing its engineering and AI capabilities. The company is also focusing on key growth markets with leadership changes in India, MEA.
The company reported strong net new bookings totaling $3 billion in Q3 FY26, a 43% year-on-year increase, reflecting the highest Annual Contract Value (ACV) bookings in four years and strong client demand for its services.
Despite strong revenue performance and raised guidance, HCLTech reported a year-on-year decline in Profit After Tax (PAT) for Q3 FY26, attributed to a ₹956 crore one-time charge related to new labor codes. The company also noted a slight YoY decrease in EBIT margin due to restructuring expenses.
HCLTech held its Q3 FY26 earnings conference call on January 12, 2026. Investors anticipate the announcement of Q4 FY26 results, typically scheduled for April 2026.
Corporate Announcements
